[1] Liu H, Yang XL, Xu HB. Advances in studies on Erigeron breviscapus [J]. Chin Tradit Herb Drug, 2002, 33 : 566-568. [2] Zhang J, Li XS, Zhang WD. The advance in studies on chemical component and pharmacology of Erigeron breviscapus [J]. J Pharm Pract, 2002, 20 : 103-107. [3] Hong H, Liu GQ. Protection against hydrogen peroxide-induced cytotoxicity in PC12 cells by scutellarin [J]. Life Sci, 2004, 74 : 2959-2973. [4] Liu YM, Lin AH, Chen H, et al. Study on pharmacokinetics of scutellarin in rabbits [J]. Acta Pharm Sin, 2003, 38 : 775-778. [5] Zhong DF, Yang BH, XY Chen, et al. Determination of scutellarin in rat plasma by high-performance liquid chromatography with ultraviolet detection [J]. J Chromatogr B, 2003, 796 : 439-444. [6] Jiang XH, Li SH, Lan K, et al. Study on the pharmacokinetics of scutellarin in dogs [J]. Acta Pharm Sin, 2003, 38 : 371-373. [7] Ge QH, Zhou Z, Zhi XJ, et al. Pharmacokinetics and absolute bioavailability of breviscapine in beagle dogs [J]. Chin J Pharm, 2003, 34 : 618-620. [8] Kazuo I, Takashi F, Yasuji K. Determination of rutin in human plasma by high-performance chromatography utilizing solid-phase extraction and ultraviolet detection [J]. J Chromatogr B, 2001, 759 : 161-168. [9] Erlund I, Kosonen T, Alfthan G, et al. Pharmacokinetics of quercetin from quercetin aglycone and rutin in healthy volunteers [J]. Eur J Clin Pharmacol, 2000, 56 : 545-553. [10] Hsiu SL, Huang TY, Hou YC, et al. Comparison of metabolic pharmacokinetics of naringin and narigenin in rabbits [J]. Life Sci, 2002, 70 : 1481-1489. |